Jin Dong
4PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Apr 14, 2026
Is a Clinical Trial With a Non-Bioequivalent Batch Necessary? The Critical Role of Intrasubject Variability in Olaparib Formulation Bridging by PBPK.Jin Dong, Andrea Moir, Xavier Pepin
|Dec 23, 2025
Minor Contribution of UGT1A1 Inhibition to Atazanavir-Related Bilirubin Elevation Supported by Conservative PBPK Modeling and Clinical Data.Jin Dong, Pradeep Sharma, Rasha Emara
|Dec 14, 2024
Inhibition of OATP1B1/3 Rather Than UGT1A1 May Be the Major Cause of the Bilirubin Elevation After Atazanavir Administration.Jin Dong, Pradeep Sharma, Rasha Emara
|Jun 28, 2023
Understanding Statin-Roxadustat Drug-Drug-Disease Interaction Using Physiologically-Based Pharmacokinetic Modeling.Jin Dong, Luna Prieto Garcia, Yingbo Huang
Pageof 1
Frequent Collaborators
4 joint publications
Weifeng Tang
3 joint publications
Mats Någård
3 joint publications
Diansong Zhou
2 joint publications
Pradeep Sharma
2 joint publications
Rasha Emara
2 joint publications
Derek Cheung
2 joint publications
David W Boulton
2 joint publications
Miki S Park
1 joint publications
Luna Prieto Garcia
1 joint publications
Yingbo Huang
